Scali

Scailyte is a Swiss-based precision medicine company that specializes in the discovery of complex disease biomarkers through single-cell data analysis. The company's core technology, ScaiVision, utilizes artificial intelligence and deep learning to analyze high-dimensional single-cell datasets, identifying unique cellular signatures associated with specific clinical conditions. Scailyte focuses on areas with high unmet medical needs, such as endometriosis and oncology, where traditional diagnostic methods are often insufficient. By translating complex cellular data into actionable clinical insights, the company aims to enable earlier diagnosis and more personalized treatment strategies. Scailyte operates through strategic partnerships with pharmaceutical companies and clinical institutions to validate and commercialize its diagnostic solutions.